Overview

To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Herpetic Neuralgia

Status:
Recruiting
Trial end date:
2023-07-10
Target enrollment:
Participant gender:
Summary
Investigate the efficacy and safety of HSK16149 capsules in Chinese herpetic Neuralgia following 4 weeks treatment in comparison to pregabalin.
Phase:
Phase 2
Details
Lead Sponsor:
Haisco Pharmaceutical Group Co., Ltd.
Treatments:
Pregabalin